Tag: risk-based approach

ICH Guidelines Q12: Navigating the Landscape of Lifecycle Management in Pharmaceuticals

Discover the significance of ICH Guidelines Q12 in the pharmaceutical industry. Learn how this international guideline fosters global harmonization, encourages regulatory flexibility, and outlines key components such as lifecycle management planning and control strategies. Explore the benefits of implementing ICH Q12, including streamlined regulatory processes and a risk-based approach to decision-making. Uncover answers to frequently asked questions about ICH Q12, from post-approval changes to its role in balancing innovation and regulatory compliance. Stay informed about the pivotal role ICH Q12 plays in shaping the future of pharmaceutical product lifecycle management.

Understanding ICH Guidelines Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients (APIs)

Discover the significance of ICH Q7 guidelines in the pharmaceutical industry. Explore key aspects such as quality management, risk-based approaches, documentation requirements, and personnel training. Learn how adherence to ICH Q7 ensures global consistency and high standards in Active Pharmaceutical Ingredient (API) manufacturing. Stay informed about facility and equipment guidelines, change control practices, and more for robust pharmaceutical quality assurance.